1163 GENES FOUND
Show / hide columns »
XML |
RDF |
TAB |
« prev | Page next »
ATP6V0D1 ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 Plasma proteins Expressed in all
ATP6V1A ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A Enzymes Nucleus Expressed in all
ATP6V1B2 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 Disease related genes Vesicles Expressed in all
ATP6V1C1 ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 Predicted intracellular proteins Nucleoplasm Expressed in all
ATP6V1C2 ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 Predicted intracellular proteins Mitochondria Tissue enhanced
ATP6V1E1 ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 Plasma proteins Nucleoplasm Expressed in all
ATP6V1F ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F Predicted intracellular proteins Expressed in all
ATP6V1G1 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 Plasma proteins Nucleus Expressed in all
ATP6V1G3 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 Predicted intracellular proteins Tissue enriched
ATP6V1H ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H Predicted intracellular proteins Actin filaments Expressed in all
ATP7A ATPase, Cu++ transporting, alpha polypeptide Disease related genes Golgi apparatus Mixed
ATP7B ATPase, Cu++ transporting, beta polypeptide Cancer-related genes Golgi apparatus Mixed
ATP8A1 ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 Enzymes Vesicles Tissue enhanced
ATP8B1 ATPase, aminophospholipid transporter, class I, type 8B, member 1 Disease related genes Expressed in all
AVPR1B Arginine vasopressin receptor 1B FDA approved drug targets Not detected
AVPR2 Arginine vasopressin receptor 2 Disease related genes Tissue enhanced
BACE1 Beta-site APP-cleaving enzyme 1 Enzymes Plasma membrane Expressed in all
BAK1 BCL2-antagonist/killer 1 Predicted membrane proteins Expressed in all
BASP1 Brain abundant, membrane attached signal protein 1 Plasma proteins Plasma membrane Tissue enhanced
BAX BCL2-associated X protein Cancer-related genes Expressed in all
BCAP29 B-cell receptor-associated protein 29 Predicted intracellular proteins Cytosol Expressed in all
BCAP31 B-cell receptor-associated protein 31 Disease related genes Endoplasmic reticulum Expressed in all
BCL2L1 BCL2-like 1 Cancer-related genes Mitochondria Expressed in all
BCL2L2 BCL2-like 2 Cancer-related genes Expressed in all
BCL2L2-PABPN1 BCL2L2-PABPN1 readthrough Cancer-related genes Mixed
BEST1 Bestrophin 1 Disease related genes Mixed
BEST2 Bestrophin 2 Predicted intracellular proteins Tissue enhanced
BNIP3 BCL2/adenovirus E1B 19kDa interacting protein 3 Cancer-related genes Cytosol Expressed in all
BNIP3L BCL2/adenovirus E1B 19kDa interacting protein 3-like Cancer-related genes Nuclear speckles Expressed in all
BPI Bactericidal/permeability-increasing protein Predicted intracellular proteins Tissue enriched
BRI3BP BRI3 binding protein Predicted membrane proteins Nucleoplasm Mixed
BSG Basigin (Ok blood group) Blood group antigen proteins Vesicles Expressed in all
BSND Barttin CLCNK-type chloride channel accessory beta subunit Disease related genes Tissue enriched
C1QBP Complement component 1, q subcomponent binding protein Cancer-related genes Plasma membrane Expressed in all
C6 Complement component 6 Cancer-related genes Group enriched
C8A Complement component 8, alpha polypeptide Disease related genes Tissue enriched
CACFD1 Calcium channel flower domain containing 1 Predicted membrane proteins Nucleoplasm Expressed in all
CACNA1A Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit Disease related genes Nucleoplasm Tissue enhanced
CACNA1C Calcium channel, voltage-dependent, L type, alpha 1C subunit Disease related genes Tissue enhanced
CACNA1F Calcium channel, voltage-dependent, L type, alpha 1F subunit Disease related genes Mixed
CACNA1H Calcium channel, voltage-dependent, T type, alpha 1H subunit Disease related genes Nucleoplasm Tissue enhanced
CACNA2D1 Calcium channel, voltage-dependent, alpha 2/delta subunit 1 FDA approved drug targets Mixed
CACNA2D2 Calcium channel, voltage-dependent, alpha 2/delta subunit 2 FDA approved drug targets Vesicles Tissue enriched
CACNA2D3 Calcium channel, voltage-dependent, alpha 2/delta subunit 3 Predicted intracellular proteins Nucleus Tissue enhanced
CACNB2 Calcium channel, voltage-dependent, beta 2 subunit Disease related genes Mixed
CACNB3 Calcium channel, voltage-dependent, beta 3 subunit FDA approved drug targets Golgi apparatus Mixed
CACNB4 Calcium channel, voltage-dependent, beta 4 subunit Disease related genes Tissue enhanced
CACNG1 Calcium channel, voltage-dependent, gamma subunit 1 FDA approved drug targets Tissue enriched
CACNG2 Calcium channel, voltage-dependent, gamma subunit 2 Disease related genes Tissue enriched
CACNG3 Calcium channel, voltage-dependent, gamma subunit 3 Predicted membrane proteins Tissue enriched
« prev | Page next »
